Trevi Therapeutics's total assets for Q4 2024 were $110.90M, an increase of 60.94% from the previous quarter. TRVI total liabilities were $11.26M for the fiscal quarter, a 13.25% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.